Vakkalanka; Swaroop K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vakkalanka; Swaroop K..The latest application filed is for "methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxide".

Company Profile

24.31.43

Vakkalanka; Swaroop K. - Basel CH
Vakkalanka; Swaroop K. - La Chaux-de-Fonds CH
Vakkalanka; Swaroop K. - Hyderabad IN
Vakkalanka; Swaroop K - La Chaux-de-Fonds CH
Vakkalanka; Swaroop K. - Lu Chaux-de-Fonds CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Treating Autoimmune, Respiratory And Inflammatory Disorders By Inhalation Of Roflumilast N-oxide App 20220008400 - Vakkalanka; Swaroop K.	2022-01-13
Novel Compounds As Modulators Of Protein Kinases App 20210401840 - Nagarathnam; Dhanapalan ; et al.	2021-12-30
Novel Selective Pi3k Delta Inhibitors App 20210403475 - Vakkalanka; Swaroop K. ; et al.	2021-12-30
Forms Of A Pi3k Delta Selective Inhibitor For Use In Pharmaceutical Formulations App 20210269446 - Vakkalanka; Swaroop K.	2021-09-02
Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast N-oxide Grant 11,103,488 - Vakkalanka August 31, 2	2021-08-31
Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor Grant 11,065,236 - Vakkalanka , et al. July 20, 2	2021-07-20
Intermediates useful in the synthesis of compounds as modulators of protein kinases Grant 11,020,399 - Nagarathnam , et al. June 1, 2	2021-06-01
Selective PI3K delta inhibitors Grant 10,981,919 - Vakkalanka , et al. April 20, 2	2021-04-20
Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations Grant 10,947,244 - Vakkalanka March 16, 2	2021-03-16
Dual Selective Pi3 Delta And Gamma Kinase Inhibitors App 20210032248 - Vakkalanka; Swaroop K. ; et al.	2021-02-04
Novel Glutaminase Inhibitors App 20210032236 - Bhavar; Prashant K ; et al.	2021-02-04
Dual selective P13 delta and gamma kinase inhibitors Grant 10,851,107 - Vakkalanka , et al. December 1, 2	2020-12-01
Novel Selective Pi3k Delta Inhibitors App 20200270258 - Vakkalanka; Swaroop K ; et al.	2020-08-27
Pharmaceutical Compositions Containing A Pde4 Inhibitor And A P13 Delta Or Dual P13 Delta-gamma Kinase Inhibitor App 20200237735 - Vakkalanka; Swaroop K ; et al.	2020-07-30
Novel Kinase Modulators App 20200239427 - Muthuppalaniappan; Meyyappan ; et al.	2020-07-30
Selective Dual Inhibitors Of Pi3 Delta And Gamma Protein Kinases App 20200199133 - Bhavar; Prashant K. ; et al.	2020-06-25
Modulators of calcium release-activated calcium channel Grant 10,668,051 - Muthuppalaniappan , et al.	2020-06-02
Glutaminase inhibitors Grant 10,611,759 - Bhavar , et al.	2020-04-07
3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases Grant 10,590,129 - Muthuppalaniappan , et al.	2020-03-17
Selective PI3K delta inhibitors Grant 10,570,142 - Vakkalanka , et al. Feb	2020-02-25
Kinase modulators Grant 10,538,501 - Muthuppalaniappan , et al. Ja	2020-01-21
Forms Of A Pi3k Delta Selective Inhibitor For Use In Pharmaceutical Formulations App 20190382411 - Vakkalanka; Swaroop K.	2019-12-19
Novel Compounds As Modulators Of Protein Kinases App 20190282581 - Nagarathnam; Dhanapalan ; et al.	2019-09-19
Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations Grant 10,414,773 - Vakkalanka Sept	2019-09-17
Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor Grant 10,413,532 - Vakkalanka , et al. Sept	2019-09-17
Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine And 3,5-disubstituted -3h-[1,2,3]triazolo[4,5-b] Pyridine Compounds As Modulat App 20190218211 - Muthuppalaniappan; Meyyappan ; et al.	2019-07-18
Selective Dual Inhibitors Of Pi3 Delta And Gamma Protein Kinases App 20190202836 - Bhavar; Prashant K ; et al.	2019-07-04
Novel Selective Pi3k Delta Inhibitors App 20190194206 - Vakkalanka; Swaroop K. ; et al.	2019-06-27
Substituted chromenones as modulators of protein kinases Grant 10,322,130 - Nagarathnam , et al.	2019-06-18
Substituted Chromenones As Modulators Of Protein Kinases App 20190105324 - Nagarathnam; Dhanapalan ; et al.	2019-04-11
Modulators of calcium release-activated calcium channel Grant 10,246,450 - Muthuppalaniappan , et al.	2019-04-02
Pharmaceutical Compositions Containing A Pde4 Inhibitor And A Pi3 Delta Or Dual Pi3 Delta-gamma Kinase Inhibitor App 20190083475 - Vakkalanka; Swaroop K. ; et al.	2019-03-21
Compounds as modulators of protein kinases Grant 10,220,035 - Nagarathnam , et al.	2019-03-05
Process For Preparation Of Optically Pure And Optionally Substituted 2-(1-hydroxy-alkyl)-chromen-4-one Derivatives And Their Use In Preparing Pharmaceuticals App 20190038634 - Raman; Jayaraman V. ; et al.	2019-02-07
Forms Of A Pi3k Delta Selective Inhibitor For Use In Pharmaceutical Formulations App 20190016725 - Vakkalanka; Swaroop K.	2019-01-17
Selective dual inhibitors of PI3 delta and gamma protein kinases Grant 10,179,786 - Bhavar , et al. Ja	2019-01-15
Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals Grant 10,130,635 - Raman , et al. November 20, 2	2018-11-20
3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases Grant 10,087,182 - Muthuppalaniappan , et al. October 2, 2	2018-10-02
Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor Grant 10,058,539 - Vakkalanka , et al. August 28, 2	2018-08-28
Novel Modulators Of Calcium Release-activated Calcium Channel App 20180222898 - Muthuppalaniappan; Meyyappan ; et al.	2018-08-09
Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations Grant 9,969,740 - Vakkalanka May 15, 2	2018-05-15
Novel Compounds As Modulators Of Protein Kinases App 20180110783 - Nagarathnam; Dhanapalan ; et al.	2018-04-26
Modulators of calcium release-activated calcium channel Grant 9,944,631 - Muthuppalaniappan , et al. April 17, 2	2018-04-17
Process For Preparation Of Optically Pure And Optionally Substituted 2-(1-hydroxy-alkyl)-chromen-4-one Derivatives And Their Use In Preparing Pharmaceuticals App 20180098994 - VENKAT RAMAN; Jayaraman ; et al.	2018-04-12
Novel Glutaminase Inhibitors App 20180057487 - Bhavar; Prashant K ; et al.	2018-03-01
Novel Compounds As Modulators Of Gpr-119 App 20170342089 - Nagarathnam; Dhanapalan ; et al.	2017-11-30
Dual Selective Pi3 Delta And Gamma Kinase Inhibitors App 20170334914 - Vakkalanka; Swaroop K. ; et al.	2017-11-23
Pharmaceutical Compositions Containing A Pde4 Inhibitor And A Pi3 Delta Or Dual Pi3 Delta-gamma Kinase Inhibitor App 20170319558 - Vakkalanka; Swaroop K. ; et al.	2017-11-09
Novel Modulators Of Calcium Release-activated Calcium Channel App 20170313690 - Muthuppalaniappan; Meyyappan ; et al.	2017-11-02
Glutaminase inhibitors Grant 9,783,533 - Bhavar , et al. October 10, 2	2017-10-10
Compounds as modulators of GPR-119 Grant 9,777,018 - Nagarathnam , et al. October 3, 2	2017-10-03
Process For Preparation Of Optically Pure And Optionally Substituted 2-(1-hydroxy-alkyl)-chromen-4-one Derivatives And Their Use In Preparing Pharmaceuticals App 20170266196 - VENKAT RAMAN; Jayaraman ; et al.	2017-09-21
Modulators of calcium release-activated calcium channel Grant 9,758,514 - Muthuppalaniappan , et al. September 12, 2	2017-09-12
Immunomodulator and anti-inflammatory compounds Grant 9,758,474 - Muthuppalaniappan , et al. September 12, 2	2017-09-12
Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine And 3,5-disubstituted-3h-[1,2,3]triazolo[4,5-b] Pyridine Compounds As Modulators Of Protein Kinases App 20170240542 - MUTHUPPALANIAPPAN; Meyyappan ; et al.	2017-08-24
Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor Grant 9,737,521 - Vakkalanka , et al. August 22, 2	2017-08-22
Selective Dual Inhibitors Of Pi3 Delta And Gamma Protein Kinases App 20170204106 - Bhavar; Prashant K. ; et al.	2017-07-20
Selective dual inhibitors of PI3 delta and gamma protein kinases Grant 9,708,329 - Bhavar , et al. July 18, 2	2017-07-18
Methods Of Treating Autoimmune, Respiratory And Inflammatory Disorders By Inhalation Of Roflumilast N-oxide App 20170196843 - Vakkalanka; Swaroop K.	2017-07-13
Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast N-oxide Grant 9,649,302 - Vakkalanka May 16, 2	2017-05-16
Improved Forms Of A Pi3k Delta Selective Inhibitor For Use In Pharmaceutical Formulations App 20170121336 - VAKKALANKA; Swaroop K.	2017-05-04
Novel Kinase Modulators App 20160318890 - MUTHUPPALANIAPPAN; Meyyappan ; et al.	2016-11-03
Novel Glutaminase Inhibitors App 20160318921 - BHAVAR; Prashant K. ; et al.	2016-11-03
Kinase modulators Grant 9,421,209 - Muthuppalaniappan , et al. August 23, 2	2016-08-23
Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals Grant 9,309,216 - Raman , et al. April 12, 2	2016-04-12
Selective Dual Inhibitors Of Pi3 Delta And Gamma Protein Kinases App 20150376188 - BHAVAR; Prashant K. ; et al.	2015-12-31
Novel Compounds As Modulators Of Gpr-119 App 20150361092 - Nagarathnam; Dhanapalan ; et al.	2015-12-17
Novel Compounds As Modulators Of Protein Kinases App 20150320752 - NAGARATHNAM; Dhanapalan ; et al.	2015-11-12
Pharmaceutical Compositions Containing A Pde4 Inhibitor And A Pi3 Delta Or Dual Pi3 Delta-gamma Kinase Inhibitor App 20150272936 - Vakkalanka; Swaroop K. ; et al.	2015-10-01
Novel Kinase Modulators App 20150174131 - MUTHUPPALANIAPPAN; Meyyappan ; et al.	2015-06-25
Novel Modulators Of Calcium Release-activated Calcium Channel App 20150166526 - MUTHUPPALANIAPPAN; Meyyappan ; et al.	2015-06-18
Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine And 3,5-disubstituted -3h-[1,2,3]triazolo[4,5-b] Pyridine Compounds As Modulators Of Protein Kinases App 20150133449 - MUTHUPPALANIAPPAN; Meyyappan ; et al.	2015-05-14
Novel Process For Preparation Of Optically Pure And Optionally Substituted 2-(1-hydroxy-alkyl)-chromen-4-one Derivatives And Their Use In Preparing Pharmaceuticals App 20150087699 - Raman; Jayaraman V. ; et al.	2015-03-26
Methods Of Treating Autoimmune, Respiratory And Inflammatory Disorders By Inhalation Of Roflumilast N-oxide App 20140213560 - VAKKALANKA; Swaroop K.	2014-07-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.